Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: rebecca who wrote (4565)	9/9/1998 11:42:00 AM
From: JanyBlueEyes	Respond to of 5736

<<Have any cost analysis studies been performed comparing ccsi's instrumentation versus usual and customary costs.??>> Cost is an issue in the negotiations for distribution. It was stated that "when business discussions are completed with potential partners and/or licensees, the business models and pricing structure for the Company's medical system will be made available, along with the key terms and features of the Company's and its partners' 3-4 year business plan to achieve global market penetration, including distribution performance requirements." <<Is Elmhurst Hospital currently using CCSI's instrument on an ongoing basis or is it limited to clinical trials???>> This is a question that could best be answered by the company, I don't have the answer :-) Jane